(Q44356720)

2 December 2017

title

Inhibition of the NF-kappaB signaling pathway mediates the anti-inflammatory effects of petrosaspongiolide M. (English)

1 reference

2 December 2017

0 references

3

1 reference

2 December 2017

Inmaculada Posadas

1

1 reference

2 December 2017

Maria Carmen Terencio

2

1 reference

2 December 2017

Luigi Gomez-Paloma

4

1 reference

2 December 2017

Miguel Payá

5

1 reference

2 December 2017

Maria José Alcaraz

6

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

2 December 2017

published in

Biochemical Pharmacology

1 reference

2 December 2017

volume

65

1 reference

2 December 2017

issue

5

1 reference

2 December 2017

page(s)

887-895

1 reference

Lipid mediator networks in cell signaling: update and impact of cytokines.

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901659-3

Regulation and inhibition of phospholipase A2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901659-3

Prostaglandin levels in stimulated macrophages are controlled by phospholipase A2-activating protein and by activation of phospholipase C and D.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901659-3

Functional crosstalk between phospholipase D(2) and signaling phospholipase A(2)/cyclooxygenase-2-mediated prostaglandin biosynthetic pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901659-3

Phospholipase A2 and arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901659-3

Phospholipase A2 and arachidonate increase in bronchoalveolar lavage fluid after inhaled antigen challenge in asthmatics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901659-3

The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901659-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901659-3

Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901659-3

Petrosaspongiolides M−R: New Potent and Selective Phospholipase A2Inhibitors from the New Caledonian Marine SpongePetrosaspongianigra

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901659-3

Co-regulation between cyclo-oxygenase-2 and inducible nitric oxide synthase expression in the time-course of murine inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901659-3

Macrophage-like RAW 264 cell line and time-resolved fluoroimmunoassay (TRFIA) as tools in screening drug effects on cytokine secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901659-3

A fluorometric assay for the measurement of nitrite in biological samples.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901659-3

Selectivity of neutrophil 5-lipoxygenase and cyclo-oxygenase inhibition by an anti-inflammatory flavonoid glycoside and related aglycone flavonoids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901659-3

Inhibition of IkappaB kinase and IkappaB phosphorylation by 15-deoxy-Delta(12,14)-prostaglandin J(2) in activated murine macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901659-3

Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901659-3

Cytosolic phospholipase A2 is required for macrophage arachidonic acid release by agonists that Do and Do not mobilize calcium. Novel role of mitogen-activated protein kinase pathways in cytosolic phospholipase A2 regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901659-3

The induction of cyclooxygenase-2 mRNA in macrophages is biphasic and requires both CCAAT enhancer-binding protein beta (C/EBP beta ) and C/EBP delta transcription factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901659-3

Molecular mechanism of tumor necrosis factor-alpha production in 1-->3-B-glucan (zymosan)-activated macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901659-3

Defining therapeutic targets by using adenovirus: blocking NF-kappaB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901659-3

An upstream protein interacts with a distinct protein that binds to the cap site of the human interleukin 1 beta gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901659-3

Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901659-3

Regulation of eicosanoid biosynthesis in the macrophage. Involvement of protein tyrosine phosphorylation and modulation by selective protein tyrosine kinase inhibitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901659-3

Differential regulation of IkappaB kinase alpha and beta by two upstream kinases, NF-kappaB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901659-3

Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901659-3

Type IIA secretory phospholipase A2 up-regulates cyclooxygenase-2 and amplifies cytokine-mediated prostaglandin production in human rheumatoid synoviocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2802%2901659-3

10.1016/S0006-2952(02)01659-3

7 January 2021

Identifiers

DOI

1 reference

2 December 2017

1 reference